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Abstract
Background: It is unclear why some children with acute otitis media (AOM) have poor outcomes.
Our aim was to describe the clinical course of AOM and the associated bacterial nasopharyngeal
colonisation in a high-risk population of Australian Aboriginal children.
Methods: We examined Aboriginal children younger than eight years who had a clinical diagnosis
of AOM. Pneumatic otoscopy and video-otoscopy of the tympanic membrane (TM) and
tympanometry was done every weekday if possible. We followed children for either two weeks
(AOM without perforation), or three weeks (AOM with perforation), or for longer periods if the
infection persisted. Nasopharyngeal swabs were taken at study entry and then weekly.
Results: We enrolled 31 children and conducted a total of 219 assessments. Most children had
bulging of the TM or recent middle ear discharge at diagnosis. Persistent signs of suppurative OM
(without ear pain) were present in most children 7 days (23/30, 77%), and 14 days (20/26, 77%)
later. Episodes of AOM did not usually have a sudden onset or short duration. Six of the 14 children
with fresh discharge in their ear canal had an intact or functionally intact TM. Perforation size
generally remained very small (<2% of the TM). Healing followed by re-perforation was common.
Ninety-three nasophyngeal swabs were taken. Most swabs cultured Streptococcus pneumoniae
(82%), Haemophilus influenzae (71%), and Moraxella catarrhalis (95%); 63% of swabs cultured all three
pathogens.
Conclusion: In this high-risk population, AOM was generally painless and persistent. These
infections were associated with persistent bacterial colonisation of the nasopharynx and any
benefits of antibiotics were modest at best. Systematic follow up with careful examination and
review of treatment are required and clinical resolution cannot be assumed.
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Today, the majority of episodes of acute otitis media
(AOM) in developed countries will resolve even if they are
not treated with antibiotics. This conclusion is based on
the findings of randomised placebo-controlled trials, lon-
gitudinal studies of initially withholding antibiotic treat-
ment, and meta-analyses of randomised controlled trials.
[1-3]. However, the outcomes in children from popula-
tions where there is an increased risk of complications
remain uncertain.
We have described the onset of early and severe otitis
media in Australian Aboriginal children[4,5]. This is asso-
ciated with dense colonisation of the nasopharynx with
respiratory bacteria. In previous studies in this popula-
tion, AOM (defined as the presence of an effusion plus
bulging of the tympanic membrane (TM) or recent perfo-
ration) was frequently asymptomatic. AOM was often
present on otoscopic examination 4 weeks after onset,
despite antibiotic treatment [6]. Children with frequent
episodes of bulging of their TM were those most likely to
develop new perforations. However, we could not deter-
mine whether AOM in high-risk populations initially
responded to treatment and then recurred, or persisted
despite treatment. The aim of this study was to describe
the clinical course of AOM and the associated bacterial
nasopharyngeal colonization in Aboriginal children from




The local Human Research Ethics Committee and the
community-controlled Tiwi Health Board approved the
study. It took place in the year 2000 in a remote Aborigi-
nal community situated 70 km north of Darwin (popula-
tion 1300). The community has an average of 30 births
per year and an infant mortality rate of 30 per 1000 live
births. The standard of housing is poor and overcrowding
is common [7].
Participants
We enrolled Aboriginal children younger than eight years
who lived in the community if: i) they had AOM; ii) they
were resident in the community; and iii) parents provided
written consent for their participation. All children in this
community develop otitis media by 12 weeks of age and
around 50% experience a perforated TM in the first year of
life [4]. Children in this study were similarly prone to
severe infections and all had been treated for otitis media
in the past. Staff at the community health centre and otitis
media researchers working on other projects made the ini-
tial diagnosis. Health centre staff examined children's ears
when they presented to the children's clinic either unwell
or for follow-up of a medical condition. Researchers
examined children's ears as part of a regular 4 weekly sur-
veillance program. Children with otorrhoea that had per-
sisted for longer than six weeks were not eligible unless
they had a diagnosis of AOM in the other ear. We
attempted to assess children every weekday they were in
the study. The planned duration of follow-up was either
two weeks (AOM without perforation), or three weeks
(AOM with perforation). We followed children with per-
sistent AOM until the AOM resolved, or the study period
ended.
Clinical assessments
We used a questionnaire and review of the clinic notes to
collect information about each child's current and past ear
health. Wax and pus were removed from the ear canal
under direct vision using a voroscope (WelchAllyn
LumiView). A Siegel's speculum was used for pneumatic
otoscopy. Images of the TM were video recorded and clas-
sified on a standardised data collection form. The position
of the TM was described as retracted (R), neutral (N), mild
bulging (B1), moderate bulging (B2), and marked bulging
(B3). TMs that had a perforation that was associated with
mild, moderate, or marked bulging (P1-P3) were consid-
ered to be functionally intact. Examples of these different
positions and "pinhole perforations" are available in a
training video [8]. Tympanometry (Grason Stadler GSI-
38, Madison, Wisconsin, USA) was used in ears without
any discharge. Tympanograms were classified according
to a modified Jerger's classification [9]. Tympanograms
with a canal volume of <0.3 cm3 were excluded.
We classified children according to the ear with the more
severe acute infection. When an assessment was only suc-
cessful in one ear, we used the diagnosis of that ear and
assumed the disease was unilateral. Generally, the person
who made the initial diagnosis started antibiotic treat-
ment before referring the child to this study. Medical or
nursing research staff prescribed additional antibiotics
during the study according to population-specific, evi-
dence-based guidelines [10]. We calculated compliance
with prescribed antibiotics on a weekly basis (the number
of doses reported as taken divided by the number of doses
prescribed for that week). All families were reminded
about their medication at each assessment and some had
help in dispensing medicine from Aboriginal research
assistants.
Definitions
Our classification of otitis media was based on current
population-specific, evidence-based guidelines [10]. In
this study (where close follow-up was ensured), we used
the following criteria: i) Aerated middle ear-normal TM
mobility and Type A or C tympanogram; ii) Otitis media
with effusion (OME)-middle ear effusion behind an intact
TM identified by an air-fluid level or bubble seen throughPage 2 of 8
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B tympanogram (admittance <0.2 mmho); iii) AOM with-
out perforation-clinical diagnosis by health staff or mod-
erate to marked bulging of an intact TM plus decreased TM
mobility or Type B tympanogram; iv) AOM with perfora-
tion-evidence of recent TM perforation provided by clini-
cal history and visualisation of fresh pus in the ear canal.
The TM was intact if the perforation had already healed by
the time of the assessment, and 'functionally intact' if the
TM was bulging and the perforation could only be identi-
fied by pneumatic otoscopy; v) Chronic suppurative otitis
media (CSOM)-TM perforation with otorrhoea present
for more than six weeks; vi) Dry perforation-TM perfora-
tion with no discharge seen in the ear canal or within the
middle ear space.
AOM was cured when there was no bulging and no dis-
charge present on examination. Similarly, we described an
episode of AOM as improved if: i) the ear discharge had
resolved but bulging of the TM persisted in AOM with per-
foration, or ii) the bulging of the TM was reduced to mild
in AOM without perforation. Examples of mild, moder-
ate, and marked bulging of the TM are available in our
training video [8]. The outcome at "1 week" was deter-
mined by the examination that was closest to day 7 (at
least 5 days after the diagnosis). The outcome at "2 weeks"
was determined by the examination that was closest to
day 14 (at least 10 days after diagnosis).
Microbiology: specimen collection and processing
We took swabs of the nasopharynx (and ear discharge if
present) on up to five occasions: day 0 (the day of enrol-
ment) and days 4–7, 10–14, 17–21 and 24–28. All swabs
were then smeared for gram staining and frozen in 1.0 ml
skim-milk-glucose-glycerol broth (SMGGB). We proc-
essed swabs (after completion of clinical observations)
using standard methods that have been previously pub-
lished [4]. We tested isolates of pneumococcus for sensi-
tivity to oxacillin, penicillin, erythromycin,
sulphamethoxazole, tetracycline, and chloramphenicol
using a disc diffusion method (calibrated dichotomous
susceptibility, CDS) [11]. Colonies resistant to oxacillin or
penicillin were classified as penicillin resistant. Colonies
resistant to three or more classes of antibiotics were classi-
fied as multi-resistant. Penicillin minimum inhibitory
concentration (MIC) was determined by E-test and cate-
gorised according to the following breakpoints: suscepti-
ble <0.064 µg; intermediate resistance 0.064 – 1.0 µg/ml;
and high resistance >1.0 µg/ml.
Results
Features of participants and examinations
We enrolled 31 children in this study and completed 219
assessments. Clinic staff referred 13 children and other
researchers referred 18 children. Children referred from
the clinic were more likely to have otorrhea (8/13 versus
6/18). The mean duration of follow up was 21 days (range
3–57 days). Most children were less than 2 years of age
and had a past history of otorrhea (see Table 1). Overall,
230 tympanograms were recorded. Nearly all of these
were Type B (223/230, 97%). Tympanograms were not
done if ear discharge was present.
Initial diagnosis of AOM
Seventeen children had an initial diagnosis of AOM with-
out perforation and 14 children had AOM with perfora-
tion. Nearly all children (27/31, 87%) had at least
moderate bulging of the TM or recent discharge when they
were first seen in this study; 13 had bilateral disease
(42%). Symptoms of AOM could be assessed in 24/31
(77%) of study participants. Mothers reported otorrhea in
11/24 (46%) and ear pain in 7/24 (29%). Of the 14 chil-
dren with AOM with perforation, two had a TM that
appeared to have healed by the time of our examination
and four had a TM that was functionally intact. All perfo-
rations seen were initially tiny in size (less than 2% of the
area of the TM) and just antero-inferior to the centre of the
TM.
Antibiotic treatment
Six children were known to be receiving antibiotics effec-
tive against respiratory pathogens at the time of the initial
AOM diagnosis (amoxicillin 50 mg/kg/day). All the other
children had received antibiotics for otitis media in the
past but the time since their last treatment was not
recorded. Following diagnosis, antibiotic treatment was
started in an additional 22 children. Two of the three chil-
dren not treated initially developed moderate bulging of
the TM and started treatment on day 6–8 (A31 and A32).
One child (A19) did not receive any antibiotics. The anti-
biotics prescribed were twice daily amoxicillin (25),
amoxicillin-clavulanate (1), trimethoprim-sulphameth-
oxazole (3), or daily intramuscular procaine penicillin
Table 1: Characteristics of study participants.
Characteristic No. (%) of children
Number of children 31 (100%)
Male 15 (48%)
Age < 2 years 22 (71%)
Previous history of otorrhoea 22 (71%)
Otoscopy at start of study (per child):
Redness 24 (78%)
Bulging (intact, no discharge) 15 (49%)
Otorrhoea (<6 weeks) 14 (45%)
Perforation seen (<6 weeks) 12 (39%)
Bilateral AOM 13 (42%)Page 3 of 8
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mg/kg/day (standard deviation 15, range 25–100). Rec-
ommended treatment duration was at least 7 days for
AOM without perforation and at least 14 days for AOM
with perforation. Compliance with prescribed treatment
was poor. Overall, we documented 462/1151 prescribed
doses (40%) as taken, and estimated that 17/30 partici-
pants (57%) took less than half their recommended
treatment.
Clinical outcomes
AOM was persistent in most children from this high-risk
population (see Table 2 and Table 3). Overall, 77% of
children still signs of ongoing inflammation at the 7 day
and 14 day assessments. Very few ears returned to normal.
Of the 438 ear examinations attempted during this study,
only 5 (1%) were consistent with an aerated, intact TM
(A03 on 1 occasion, A19 on 1 occasion, and A29 on 3
occasions). Even when the acute infection resolved, recur-
rence was common. Children who received more than
50% of the prescribed antibiotics had similar rates of
treatment failure to the children who did not (75% vs
71%, Risk difference 4%, 95%CI -33, 41). Similarly, chil-
dren with a past history of otorrhea had similar rates of
treatment failure to the children who did not (68% vs
75%, Risk difference -7%, 95%CI -43, 30). There were
also no obvious differences in the clinical course of the six
children who were already on antibiotics when they were
enrolled in the study.
Seventeen children (55%) had a TM perforation docu-
mented at some point during the study. Of the 4 children
with AOM with perforation who were followed for 6
weeks, 3 had healing and recurrence of their TM perfora-
tion documented. None of these four children had the
typical otoscopic features of CSOM. In all cases the perfo-
ration was too small (usually a "pinhole") to allow
adequate delivery of topical antibiotics to the middle ear
space.
Microbiological outcomes
Overall, 93 nasopharyngeal swabs (31 children) and 38
swabs of ear discharge (13 children) were taken during
this study. Each child was eligible for a maximum of five
swabs (mean 3). Most of the nasopharyngeal swabs were
positive for S. pneumoniae (76/93, 82%), H. influenzae
(66/93, 71%) or M. catarrhalis (86/93, 95%). All but two
of the nasopharyngeal swabs were positive for at least 1
pathogen (98%), and 59/93 (63%) were positive for all
three otitis media pathogens. Antibiotic sensitivity testing
was done in 74 of the 76 nasopharyngeal swabs positive
for S. pneumoniae. Of these, 59/74 (80%) were penicillin
resistant and 23/74 (31%) were multi-resistant. E-tests
were available for 44 of the 59 penicillin resistant isolates:
3/44 (7%) were highly penicillin resistant.
We were able to take an initial swab in 27/31 children. All
but one of these swabs were positive for at least one path-
ogen, and 18/27 (67%) were positive for all three otitis
media pathogens-see Table 4. The prescription of antibi-
otics did not reduce carriage of these pathogens at follow
Table 2: Clinical outcomes at 7 days after diagnosis of acute otitis media (AOM). AOM was considered cured when there was no 
bulging and no discharge present on examination. An episode of AOM was considered improved if: i) the ear discharge had resolved 
but bulging of the TM persisted in AOM with perforation; or ii) the bulging of the TM was reduced to mild in AOM without 
perforation. Despite improvement, these children still had persistent signs of suppurative infection.
Cure (%) Improved (%) Not Improved (%)
AOM without Perforation (n = 16) 6 (38%) 1 (6%) 9 (56%)
AOM with Perforation (n = 14) 1 (7%) 3 (21%) 10 (71%)
TOTAL (n = 30) 7 (23%) 4 (13%) 19 (63%)
Table 3: Clinical outcomes at 14 days after diagnosis of acute otitis media (AOM). See Table 2 for explanation of diagnostic categories.
Cure (%) Improved (%) Not Improved (%)
AOM without Perforation (n = 14) 3 (21%) 1 (7%) 10 (71%)
AOM with Perforation (n = 12) 3 (25%) 1 (8%) 8 (67%)
TOTAL (n = 26) 6 (23%) 2 (8%) 18 (69%)Page 4 of 8
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resistant pneumococci was common at diagnosis (16/27,
59%). This did not change substantially following treat-
ment-see Figure 3. The carriage of penicillin resistant
pneumococci was not associated with an increased rate of
clinical failure (62% vs 80%, Risk difference -18%, 95%CI
-62, 25).
Identification of nasopharyngeal pathogens from swabs
of ear discharge was less common: S. pneumoniae 11/38
(29%), H. influenzae 12/38 (32%), or M. catarrhalis 2/38
(5%). Nineteen ear discharge swabs (50%) were positive
for at least one of these pathogens and 1/38 (3%) was pos-
itive for all three otitis media pathogens.
Onset and progression of AOM with perforation
The changes in TM position and diagnosis over the 219
examinations are shown in Figure 1. Of the 14 children
who entered the study with a diagnosis of AOM with per-
foration, two TMs had already healed and six were func-
tionally intact (ie. pinhole perforation only seen on
pneumatic otoscopy). Both children who initially had
fresh discharge obscuring an intact TM subsequently expe-
rienced recurrent perforations (A02 and A03). In the other
12 children with identifiable perforations, discharge con-
tinued seeping through the perforation almost immedi-
ately after completing the cleaning or swabbing of the
middle ear canal. Eight TMs were initially perforated and
in the neutral position. Over time, five of these also
became functionally intact (ie. the perforation size
reduced and the TM became bulging). AOM without per-
foration progressed to perforation in three children (A01,
A10 and A26). In each case, the TM was observed to be
bulging prior to perforation. On one occasion when a new
perforation was observed, the TM had perforated and
healed again within a 24 hour period (A26).
There were two patterns of resolution of AOM with perfo-
ration. In four children, the suppurative process resolved
and the perforation became dry (A07, A18, A22, A29).
Two of these TMs subsequently healed during the study
period. More commonly, the perforation appeared to be
healing while the suppurative process was ongoing (A01,
A02, A03, A10, A12, A14, A20, A26, and A28). Perfora-
tions were observed to heal and re-perforate in 4 children
(A02, A03, A12, and A14). In one child, the right and left
TM healed and re-perforated 8 times over a 6 week period
(A02), confirming that healing and re-perforation can
occur frequently.
Discussion
This was the first study describing the clinical course of
AOM in Australian Aboriginal children. It is also the first
study providing a detailed description of otoscopy find-
ings in a population of high-risk of TM perforation. AOM
(or suppurative OM) was common, usually not associated
with ear pain, frequently bilateral, and often associated
with perforation of the TM. In this population, AOM was
generally persistent. Infections with a sudden onset and
short duration were uncommon.
Strengths and limitations of the study
We used a standardised clinical assessment that included
tympanometry and video-otoscopy. Since definitions of
AOM vary [12,13],. the detailed description of the posi-
tion and integrity of the TM over time is especially useful
(see Figure 1). This information has not been reported
previously.
Limitations of the study include the small number of chil-
dren enrolled and the number of scheduled examinations
that were missed. This is a consequence of performing
research in remote Aboriginal communities. It reflects the
challenges associated with research in remote locations
with small populations. Participating families are cultur-
ally different, highly mobile, and have competing priori-
ties that are not easily predicted. These factors make daily
follow-up difficult. The small sample size and relative
homogeneity of the study population mean that poten-
tially important factors that predict outcome may no be
identified. However, a larger study (or observation over a
longer duration) is unlikely to change our conclusion that
"persistent AOM" is common in this population (overall
risk of persistent AOM 77% 95%CI 58, 90). Since there
are currently no data available in the world on the clinical
course of AOM in a population at high-risk of AOM, the
information contained within Figure 1 is both unique and
clinically important.
Table 4: The proportion of children with bacterial pathogens isolated from their nasopharynx.
Spn (%) PRSpn (%) Hi (%) Mc (%)
Day 0 22/27 (81%) 16/27 (59%) 19/27 (70%) 26/27 (96%)
Week 1 20/24 (83%) 16/24 (67%) 17/24 (71%) 24/24 (100%)
Week 2 18/21 (86%) 13/21 (62%) 17/21 (81%) 20/21 (95%)
Spn = Streptococcus pneumoniae; PRSpn = Penicillin Resistant Streptococcus pneumoniae; Hi = Haemophilus influenzae; Mc = Moraxella catarrhalis.Page 5 of 8
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piratory pathogens are striking. The microbiological
methods used in this small study cannot determine i)
which pathogens extend from the nasopharynx to the
middle ear space; ii) the relative importance of concurrent
infection with multiple organisms; iii) the rate of acquisi-
tion of new pathogens while on treatment; or iv) the role
of antibiotic resistant bacteria. While we did not find
pneumococcal penicillin resistance of organisms in the
nasopahrynx to be a good predictor of outcome, the small
sample size mean that important effects cannot be
excluded.
Comparison with outcomes in clinical trials
Should we be surprised that "persistent AOM" is so com-
mon in this population? In published prospective studies
where children have not been treated with antibiotics, the
rate of clinical failure in the first week ranged from 2% to
83% [14-23]. The median failure rate was 24%. The most
striking influence on reported rates of clinical failure was
Position and integrity of tympanic membrane in 31 Australian Aboriginal children following a new diagnosis of acute otitis mediaFigure 1
Position and integrity of tympanic membrane in 31 Australian Aboriginal children following a new diagnosis of 
acute otitis media. Shaded = discharge present; C = chronic perforation; P = acute perforation; B = bulging; n = neutral; R = 
retracted; 0 = no bulging; 1 = mild bulging; 2 = moderate bulging; 3 = marked bulging. * = past history of otorrhea.
IDNo. Day 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42
A01* right R R R R R R
5y 10m left B3 P1 R R R R
A02* right B3 B3 B3 B2 P2 B1 B2 P0 B2 P1 B2
8m left B3 B2 P1 P0 B2 ? B3 P0 B3 P1 B3
A03 right B1 B P B2 P0 P3 B3 P0 P0 B3 B3 B2 B2 B2 R
5m left B3 B2 N ? ? B3 B3 B2 B1 B1 B2 N ? R
A04 right B2 B3 B2 R B3
8m left B3 ? B2 N B2
A05 right B2 B3 B2 B2 B3
8m left B2 B3 B2 B2 B2
A06* right R B2
14m left B2 B3
A07* right C0 C0 C0 C0 C0
4y 5m left P1 P0 P0 P0 R
A08* right R B2 B2 R
13m left B2 B3 B3 N
A09* right R R R R R R R
4y 4m left B1 B1 N N N B1 B1
A10* right ? B2 B2 B2 B2
2m left B2 P? P0 B3 B3
A11 right N N B2
3m left B2 B2 B3
A12* right B2 B1 B1 B3 R R B1 B2 B2 R N R R P0 R
4m left P2 B2 B2 B3 B2 B1 B1 B1 B1 P1 P1 B2 B2 B3 B2
A13* right P1 P2 P0 P0 P2 P2 P2 P1 P3 P2 P1 P1
11m left B1 B2 B2 B2 B2 B2 R R B1 R N B1
A14* right P0 B2 B2 B2 P0 P0 P P1 P2 P0 P0 P0
4m left P0 B2 B2 B2 B3 B3 P0 P0 B2 P1 P0 P2
A15 right B3 B2 B3 B3 B2 N
3m left B3 B2 B3 B2 B3 R
A16 right B1 R
11m left B2 B2
A17* right P0 P? P?
23m left R ? ?
A18* right P0 P0 P0 P0 P0 P0 P0 P0 P0 P0 P0 P0
13m left P0 P0 P0 P0 P0 P0 P0 P0 P0 P0 P0 P0
A19 right ? N R
34m left R R N
A20* right P2 B3 B1 R R R R R
20m left N R R R R R N R
A21* right P0 P0 P0 P1 P2 P0 P0 P? P0 P0 P0
24m left B1 B2 B1 R N R N R N N
A22* right B2 B1 B2 B1 R B2 B1 B2 N
25m left P0 P0 P0 P0 P0 P0 P0 P0 P0
A23 right B1 B1 B1 B1 B1 R B2 N
18m left B2 B2 B2 B2 B1 B1 B2 B1
A25* right N R R R R B1 R R B1
8m left B3 B1 R B2 B3 B2 B2
A26* right R N R R N R
15m left B2 B1 N N B1 N
A27* right B2 R B2 N N B3 N
21m left B2 B2 R R N B2 R
A28* right C0 C0 C0 C0 C0 C0
11m left P0 P0 P0 P1 N N
A29* right P0 P0 B2
4y 1m left N N N
A30* right P0 P0 P0 P1 P0
24m left P0 P0 P0 P1 P0
A31* right N R B3 B3
2y 8m left N B1 B2 R
A32 right R B2 B3 B2
3m left B1 B2 B2 B2
43-44 50-56Page 6 of 8
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clinical failure in terms of persistent symptoms (fever or
otalgia) reported the lowest rates of clinical failure (all
<25% at the end of the first week) [14,16-19]. The median
clinical failure rate for these studies was 15%. In contrast,
the five studies with the highest clinical failure rates
(range 38–83%, median 73%) defined clinical failure as
persistence of otoscopic signs [15,20-23]. Only one study
described both the rate of persistent symptoms (13%) and
persistent otoscopic signs (73%) after seven days [22].
Overall, these studies suggest that symptoms resolve
quickly in most children with AOM not receiving antibi-
otics while otoscopic signs do not. Consequently, we
should probably not be surprised by our findings of per-
sistent otoscopic signs in a high-risk population where
compliance with recommended antibiotic treatment is
poor and antibiotic resistance is common.
Unfortunately, in nearly all published clinical trials, there
is insufficient information to determine whether persist-
ent bulging of the TM was a common finding [24]. Persist-
ent middle ear discharge was probably unusual (as it is a
readily identified complication of AOM). None of the
studies described the outcomes specifically for the sub-
group of children who had AOM with perforation at the
time of diagnosis. Similarly, none of these studies
described the associated nasopharyngeal colonisation
during episodes of AOM. However, other studies in devel-
oped countries have found that dense colonisation with
multiple bacterial pathogens is unusual [25]. This may be
an important risk factor for the children included in this
study.
Implications of the study
For populations where perforation of the TM and CSOM
are uncommon, this study provides important informa-
tion about: i) appropriate definitions for different types of
OM; and ii) identification of individual children most at
risk of CSOM. For high-risk populations, we believe our
description of "persistent AOM" is likely to be generalisa-
ble. This persistence may be related to the severity of clin-
ical presentation, the bacterial load (multiplicity of
species and strains and their density of infection), the fre-
quency of exposure to multiple pathogenic strains, or
poor compliance with antibiotics. The early age of onset
of suppurative ear infections and the low rates of reported
symptoms make early recognition difficult. Conse-
quently, active surveillance in all infants in this popula-
tion is recommended.
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